#Breaking: #Germany’s #BioNTech SE said the #COVID-19 vaccine it is developing with partner #Pfizer will likely generate up to 17 billion euros

Germany's BioNTech SE said the COVID-19 vaccine it is developing with partner Pfizer will likely generate up to 17 billion euros ($19.6 billion) in revenues this year, as booster shots take hold and use in children increases. https://t.co/WPBqavjeXI

— Reuters Health (@Reuters_Health) November 9, 2021

Source: Twitter